TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. May 6, 2005
TCL Archive NCI To Slow New Center Development To Assure Funding For Existing Commitments, King Says February 14, 1975